BYOD: ensure all your patients’ devices meet study criteria using Exco InTouch’s mDNA® technology.
It is commonly acknowledged that using BYOD in clinical trials - where participants can either use their own mobile device for eCOA data capture or a provisioned one - can bring with it a multitude of benefits for everyone involved. But how can you be sure that the devices they’re using meet your strict study criteria?
The answer is simple. Exco InTouch’s mDNA® technology automatically identifies a patient’s device and determine whether it meets the specific criteria set out for the trial. If it doesn’t, then a device can be provisioned. So how does it work?
The patient receives a message, for example an SMS, containing a link
When the link is clicked, the device’s specification is identified, telling the participant and site investigator if it is compatible with the trial
The benefits of mDNA are clear:
Reduced time and effort, and elimination of mistakes as patients no longer need to manually find the specification of their device
Site staff do not run the risk of data security and privacy breaches by helping patients check the device specification
